KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
Patent Applications and Registrations
Patent applications and USPTO patent grants for KTB TUMORFORSCHUNGSGESELLSCHAFT MBH.The latest application filed is for "combinations of albumin-based drug delivery systems".
- KTB TUMORFORSCHUNGSGESELLSCHAFT MBH - Freiburg N/A DE
- KTB Tumorforschungsgesellschaft MBH - Freiburg im Breisgau N/A DE
- KTB TUMORFORSCHUNGSGESELLSCHAFT MBH - DE DE
- KTB Tumorforschungsgesellschaft MBH - N/A N/A N/A
- KTB Tumorforschungsgesellschaft MBH -
- KTB Tumorforschungsgesellschaft mbH - Freibur im Breisgau DE
- KTB TUMORFORSCHUNGSGESELLSCHAFT MBH - Berlin DE
Trademarks
| Patent | Date |
|---|---|
| Thioether derivatives as protein kinase inhibitors Grant 9,925,193 - Kubbutat , et al. March 27, 2 | 2018-03-27 |
| Dual acting prodrugs Grant 9,901,644 - Kratz , et al. February 27, 2 | 2018-02-27 |
| Combinations Of Albumin-Based Drug Delivery Systems App 20180028679 - Kratz; Felix ; et al. | 2018-02-01 |
| Combination Of Drugs With Protein-Binding Prodrugs App 20170319707 - KRATZ; Felix | 2017-11-09 |
| Combinations of albumin-based drug delivery systems Grant 9,801,949 - Kratz , et al. October 31, 2 | 2017-10-31 |
| Dual Acting Prodrugs App 20160346396 - KRATZ; Felix ; et al. | 2016-12-01 |
| Dual acting prodrugs Grant 9,446,138 - Kratz , et al. September 20, 2 | 2016-09-20 |
| Bisphosphonate-prodrugs Grant 9,320,803 - Kratz , et al. April 26, 2 | 2016-04-26 |
| Thioether Derivatives As Protein Kinase Inhibitors App 20150328219 - KUBBUTAT; Michael ; et al. | 2015-11-19 |
| Apparatus For The Homogenization And Separation Of Samples App 20150174539 - Eberle; Klaus-Gunter ; et al. | 2015-06-25 |
| Combinations Of Albumin-based Drug Delivery Systems App 20150023912 - Kratz; Felix ; et al. | 2015-01-22 |
| Dual Acting Prodrugs App 20140205539 - Kratz; Felix ; et al. | 2014-07-24 |
| Bisphosphonate-prodrugs Grant 8,778,914 - Kratz , et al. July 15, 2 | 2014-07-15 |
| Dual acting prodrugs Grant 8,664,181 - Kratz , et al. March 4, 2 | 2014-03-04 |
| Bisphosphonate-Prodrugs App 20140051623 - Kratz; Felix ; et al. | 2014-02-20 |
| Prodrugs Grant 8,642,555 - Kratz , et al. February 4, 2 | 2014-02-04 |
| Acid-labile trigger units Grant 8,609,860 - Warnecke , et al. December 17, 2 | 2013-12-17 |
| Linear self-eliminating oligomers Grant 8,597,631 - Warnecke December 3, 2 | 2013-12-03 |
| Combination Of Drugs With Protein-Binding Prodrugs App 20130040905 - Kratz; Felix | 2013-02-14 |
| Combined Use Of Phospholipid And Sulfate Groups-carrying Polysaccharides For Inhibiting Metastatic Spread App 20130012473 - Massing; Ulrich ; et al. | 2013-01-10 |
| Linear Self-eliminating Oligomers App 20120270937 - Warnecke; Andre | 2012-10-25 |
| Bisphosphonate-prodrugs App 20120165296 - Kratz; Felix ; et al. | 2012-06-28 |
| Acid-labile Trigger Units App 20120142711 - Warnecke; Andre ; et al. | 2012-06-07 |
| Prodrugs App 20120094892 - Kratz; Felix ; et al. | 2012-04-19 |
| Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same Grant 7,902,144 - Kratz March 8, 2 | 2011-03-08 |
| Low-viscous Anthracycline Formulation App 20100152273 - Kratz; Felix | 2010-06-17 |
| Dual Acting Prodrugs App 20100144647 - Kratz; Felix ; et al. | 2010-06-10 |
| Receptor and Antigen Targeted Prodrug App 20100111866 - Kratz; Felix | 2010-05-06 |
| Acylgycerophospholipids for treating symptoms concomitant with cancer App 20090298793 - Massing; Ulrich | 2009-12-03 |
| Tablet containing hydrogenated phospholipids App 20080187583 - Massing; Ulrich ; et al. | 2008-08-07 |
| Protein-Binding Anthracycline Peptide Derivatives and Drugs Containing Them App 20080161245 - Kratz; Felix ; et al. | 2008-07-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 